Press releases 2024
Alligator Bioscience gets US patient for Neo-X-Prime鈩
Alligator Bioscience, one of the partners at NextGenNK, was granted first U.S. patent for Neo-X-Prime鈩, the bispecific antibody ATOR-4066 for Cancer Treatment. This antibody targets CD40 present in APCs and tumor antigens simultaneously.
Zelluna moving into new clinical trial and new appointment
Zelluna Immunotherapy, a NextGenNK Partner appoints Dr Bent Jakobsen as Executive Chairman of the Board as the Company moves towards the clinic with a world鈥檚 first, 鈥渙ff the shelf鈥 MAGE-A4 TCR-NK cell therapy.
Photo: Ulf Sirborn